Receive our newsletter – data, insights and analysis delivered to you
  1. Deals Analysis
November 8, 2021

North America’s medical devices industry saw a drop of 17.95% in artificial intelligence deal activity in Q3 2021

Led by $250m private equity deal with Certara USA, North America’s medical devices industry saw a drop of 17.95% in artificial intelligence deal activity during Q3 2021, when compared to the last four-quarter average, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

 

A total of 24 artificial intelligence deals worth $896.2m were announced for the region during Q3 2021, against the last four-quarter average of 29.25 deals.

Of all the deal types, venture financing saw most activity in Q3 2021 with 19 deals, representing a 79.2% share for the region.

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

In second place was M&A with four deals, followed by private equity deals with one transactions, respectively capturing a 16.7% and 4.2% share of the overall artificial intelligence deal activity for the quarter.

In terms of value of artificial intelligence deals, venture financing was the leading category in North America’s medical devices industry with $546.15m, while private equity and M&A deals totalled $250m and $100m, respectively.

North America medical devices industry artificial intelligence deals in Q3 2021: Top deals

The top five medical devices artificial intelligence deals accounted for a 67.9% share of the overall value during Q3 2021.

The combined value of the top five artificial intelligence deals stood at $608m, against the overall value of $896.2m recorded for the quarter.

1) Mubadala Investment $250m private equity deal with Certara USA

2) The $201m venture financing of InterVenn BioSciences by Amplify Partners,Anzu Partners,Genoa Ventures,Heritage Provider Network,Irving Investors,SoftBank Group and True Ventures

3) Hibercell $100m acquisition deal with Genuity Science

4) The $30m venture financing of Iterative Scopes by Breyer Capital,Eli Lilly and,Johnson & Johnson Innovation – JJDC,Obvious Ventures and Seae Ventures

5) Crosslink Capital,E14 Fund,General Catalyst Partners and Insight Partners $27m venture financing deal with Overjet

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU